Information about shares issued by INVL Technology and votes granted
- 45
Please be informed, that on 24 February 2025 INVL Technology has transferred part of its shares – 1,143 units – to the employees of INVL Technology's subsidiaries, who acquired the right to realization of the option right under the basis and terms of signed option agreements. Considering this, INVL Technology hereby announces the data on its issued shares as of 24 February 2025:
Type of shares | Number of shares and total voting rights granted by the issued shares, units | Number of votes for the quorum of the General Shareholders Meeting, units | Nominal value, EUR | Total nominal Value and authorized capital, EUR | Portion of the authorized capital, % |
Ordinary registered shares | 12,175,321 | 12,009,566 | 0.29 | 3,530,843.09 | 100 |
The person authorized to provide additional information:
INVL Technology Managing Partner
Kazimieras Tonkūnas
E-mail [email protected]

GlobeNewsWire
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.
Lastest news
- AerSale Announces Appointment of Thomas Mullins to its Board of Directors
- CRBU DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBU
- ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
- New Bestselling Book to Help Outmarket Competition
- MERCK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK
- AEON Biopharma, Inc. Announces Reverse Stock Split
Lastest videos